ID   PSA_HUMAN               Reviewed;         919 AA.
AC   P55786; B7Z463; Q6P145; Q9NP16; Q9UEM2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 2.
DT   07-JAN-2015, entry version 141.
DE   RecName: Full=Puromycin-sensitive aminopeptidase;
DE            Short=PSA;
DE            EC=3.4.11.14;
DE   AltName: Full=Cytosol alanyl aminopeptidase;
DE            Short=AAP-S;
GN   Name=NPEPPS; Synonyms=PSA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=9048733;
RA   Tobler A.R., Constam D.B., Schmitt-Graeff A., Malipiero U.,
RA   Schlapbach R., Fontana A.;
RT   "Cloning of the human puromycin-sensitive aminopeptidase and evidence
RT   for expression in neurons.";
RL   J. Neurochem. 68:889-897(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 31-919 (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 45-919 (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=11435692;
RA   Bauer W.O., Nanda I., Beck G., Schmid M., Jakob F.;
RT   "Human puromycin-sensitive aminopeptidase: cloning of 3' UTR, evidence
RT   for a polymorphism at a.a. 140 and refined chromosomal localization to
RT   17q21.";
RL   Cytogenet. Cell Genet. 92:221-224(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 45-85.
RX   PubMed=10329370; DOI=10.1006/bbrc.1999.0604;
RA   Thompson M.W., Tobler A., Fontana A., Hersh L.B.;
RT   "Cloning and analysis of the gene for the human puromycin-sensitive
RT   aminopeptidase.";
RL   Biochem. Biophys. Res. Commun. 258:234-240(1999).
RN   [7]
RP   PROTEIN SEQUENCE OF 46-105, FUNCTION, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10978616; DOI=10.1016/S0379-0738(00)00280-2;
RA   Yamamoto Y., Li Y.H., Ushiyama I., Nishimura A., Ohkubo I., Nishi K.;
RT   "Puromycin-sensitive alanyl aminopeptidase from human liver cytosol:
RT   purification and characterization.";
RL   Forensic Sci. Int. 113:143-146(2000).
RN   [8]
RP   FUNCTION.
RX   PubMed=11062501; DOI=10.1038/80852;
RA   Stoltze L., Schirle M., Schwarz G., Schroter C., Thompson M.W.,
RA   Hersh L.B., Kalbacher H., Stevanovic S., Rammensee H.G., Schild H.;
RT   "Two new proteases in the MHC class I processing pathway.";
RL   Nat. Immunol. 1:413-418(2000).
RN   [9]
RP   MUTAGENESIS OF GLU-353 AND TYR-438, AND ACTIVE SITE.
RX   PubMed=12729622; DOI=10.1016/S0003-9861(03)00123-1;
RA   Thompson M.W., Govindaswami M., Hersh L.B.;
RT   "Mutation of active site residues of the puromycin-sensitive
RT   aminopeptidase: conversion of the enzyme into a catalytically inactive
RT   binding protein.";
RL   Arch. Biochem. Biophys. 413:236-242(2003).
RN   [10]
RP   FUNCTION, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17154549; DOI=10.1021/bi061830d;
RA   Sengupta S., Horowitz P.M., Karsten S.L., Jackson G.R.,
RA   Geschwind D.H., Fu Y., Berry R.W., Binder L.I.;
RT   "Degradation of tau protein by puromycin-sensitive aminopeptidase in
RT   vitro.";
RL   Biochemistry 45:15111-15119(2006).
RN   [11]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=17318184; DOI=10.1038/sj.emboj.7601592;
RA   Bhutani N., Venkatraman P., Goldberg A.L.;
RT   "Puromycin-sensitive aminopeptidase is the major peptidase responsible
RT   for digesting polyglutamine sequences released by proteasomes during
RT   protein degradation.";
RL   EMBO J. 26:1385-1396(2007).
RN   [12]
RP   FUNCTION.
RX   PubMed=19917696; DOI=10.4049/jimmunol.0901489;
RA   Kim E., Kwak H., Ahn K.;
RT   "Cytosolic aminopeptidases influence MHC class I-mediated antigen
RT   presentation in an allele-dependent manner.";
RL   J. Immunol. 183:7379-7387(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Aminopeptidase with broad substrate specificity for
CC       several peptides. Involved in proteolytic events essential for
CC       cell growth and viability. May act as regulator of neuropeptide
CC       activity. Plays a role in the antigen-processing pathway for MHC
CC       class I molecules. Involved in the N-terminal trimming of
CC       cytotoxic T-cell epitope precursors. Digests the poly-Q peptides
CC       found in many cellular proteins. Digests tau from normal brain
CC       more efficiently than tau from Alzheimer disease brain.
CC       {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:11062501,
CC       ECO:0000269|PubMed:17154549, ECO:0000269|PubMed:17318184,
CC       ECO:0000269|PubMed:19917696}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal amino acid,
CC       preferentially alanine, from a wide range of peptides, amides and
CC       arylamides.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Strongly inhibited by bestatin, leuhistin,
CC       actinonin, amastatin, 1,10-phenanthroline, DFP, PCMBS, Zn(2+),
CC       Cd(2+), Co(2+), Cu(2+), Hg(2+), EDTA and puromycin. Not inhibited
CC       by PMSF, and only slightly inhibited by leupeptin and aprotinin.
CC       Activity is increased by Mg(2+) and Ca(2+).
CC       {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549,
CC       ECO:0000269|PubMed:17318184}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.20 mM for Lys-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=0.25 mM for Leu-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=0.27 mM for Ala-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=0.80 mM for Met-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=0.47 mM for Pro-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=0.21 mM for Val-p-NA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=182 uM for Ala-MCA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=189 uM for Met-MCA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=220 uM for Lys-MCA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=91 uM for Leu-MCA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC         KM=167 uM for Phe-MCA {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC       pH dependence:
CC         Optimum pH is 7.5. Stable from pH 5.0 to 8.0.
CC         {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549};
CC       Temperature dependence:
CC         Stable up to 40 degrees Celsius. {ECO:0000269|PubMed:10978616,
CC         ECO:0000269|PubMed:17154549};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10978616}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:10978616}. Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55786-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55786-2; Sequence=VSP_056446, VSP_056447;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in liver, epithelium of renal
CC       tubules, epithelium of small and large intestine, gastric
CC       epithelial cells, and alveoli of the lung (at protein level).
CC       {ECO:0000269|PubMed:10978616}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-45 is the initiator.
CC       N-terminal sequencing in PubMed:10978616 suggests that Met-45 is
CC       used, followed by methionine initiator removal. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH65294.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA68964.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y07701; CAA68964.1; ALT_INIT; mRNA.
DR   EMBL; AK296887; BAH12449.1; -; mRNA.
DR   EMBL; AC025682; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC065294; AAH65294.2; ALT_INIT; mRNA.
DR   EMBL; AJ132583; CAA10709.1; -; mRNA.
DR   EMBL; AF252387; AAF70086.1; -; Genomic_DNA.
DR   CCDS; CCDS45721.1; -. [P55786-1]
DR   RefSeq; NP_006301.3; NM_006310.3. [P55786-1]
DR   UniGene; Hs.443837; -.
DR   ProteinModelPortal; P55786; -.
DR   SMR; P55786; 42-910.
DR   BioGrid; 114897; 42.
DR   IntAct; P55786; 6.
DR   MINT; MINT-4999844; -.
DR   STRING; 9606.ENSP00000320324; -.
DR   BindingDB; P55786; -.
DR   ChEMBL; CHEMBL2264; -.
DR   MEROPS; M01.010; -.
DR   PhosphoSite; P55786; -.
DR   DMDM; 51704228; -.
DR   MaxQB; P55786; -.
DR   PaxDb; P55786; -.
DR   PeptideAtlas; P55786; -.
DR   PRIDE; P55786; -.
DR   Ensembl; ENST00000322157; ENSP00000320324; ENSG00000141279. [P55786-1]
DR   GeneID; 9520; -.
DR   KEGG; hsa:9520; -.
DR   UCSC; uc002ilr.4; human. [P55786-1]
DR   CTD; 9520; -.
DR   GeneCards; GC17P045608; -.
DR   H-InvDB; HIX0013922; -.
DR   HGNC; HGNC:7900; NPEPPS.
DR   HPA; HPA021453; -.
DR   HPA; HPA045649; -.
DR   MIM; 606793; gene.
DR   neXtProt; NX_P55786; -.
DR   PharmGKB; PA31703; -.
DR   eggNOG; COG0308; -.
DR   GeneTree; ENSGT00760000119082; -.
DR   HOGENOM; HOG000106482; -.
DR   HOVERGEN; HBG106325; -.
DR   InParanoid; P55786; -.
DR   KO; K08776; -.
DR   OMA; IVPKDRV; -.
DR   PhylomeDB; P55786; -.
DR   TreeFam; TF300395; -.
DR   Reactome; REACT_75842; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; NPEPPS; human.
DR   GeneWiki; NPEPPS; -.
DR   GenomeRNAi; 9520; -.
DR   NextBio; 35479397; -.
DR   PMAP-CutDB; P55786; -.
DR   PRO; PR:P55786; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; P55786; -.
DR   CleanEx; HS_NPEPPS; -.
DR   ExpressionAtlas; P55786; baseline and differential.
DR   Genevestigator; P55786; -.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004177; F:aminopeptidase activity; TAS:ProtInc.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR014782; Peptidase_M1_N.
DR   PANTHER; PTHR11533; PTHR11533; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aminopeptidase; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Metal-binding; Metalloprotease;
KW   Nitration; Nucleus; Protease; Reference proteome; Zinc.
FT   CHAIN         1    919       Puromycin-sensitive aminopeptidase.
FT                                /FTId=PRO_0000095116.
FT   REGION      316    320       Substrate binding. {ECO:0000250}.
FT   MOTIF       726    730       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    353    353       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       352    352       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       356    356       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       375    375       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   BINDING     180    180       Substrate. {ECO:0000250}.
FT   SITE        438    438       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES     464    464       Nitrated tyrosine. {ECO:0000250}.
FT   VAR_SEQ       1     44       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056446.
FT   VAR_SEQ     181    216       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056447.
FT   MUTAGEN     353    353       E->A: Reduces catalytic activity by
FT                                25,000-fold to 100,000-fold.
FT                                {ECO:0000269|PubMed:12729622}.
FT   MUTAGEN     353    353       E->Q: Reduces catalytic activity by
FT                                5,000-fold to 15,000-fold.
FT                                {ECO:0000269|PubMed:12729622}.
FT   MUTAGEN     353    353       E->V: Reduces catalytic activity by
FT                                300,000-fold to 500,000-fold.
FT                                {ECO:0000269|PubMed:12729622}.
FT   MUTAGEN     438    438       Y->F: Reduces catalytic activity by
FT                                1,000-fold to 2,500-fold.
FT                                {ECO:0000269|PubMed:12729622}.
FT   CONFLICT    184    184       A -> P (in Ref. 1; CAA68964).
FT                                {ECO:0000305}.
SQ   SEQUENCE   919 AA;  103276 MW;  873C9BF75494A057 CRC64;
     MWLAAAAPSL ARRLLFLGPP PPPLLLLVFS RSSRRRLHSL GLAAMPEKRP FERLPADVSP
     INYSLCLKPD LLDFTFEGKL EAAAQVRQAT NQIVMNCADI DIITASYAPE GDEEIHATGF
     NYQNEDEKVT LSFPSTLQTG TGTLKIDFVG ELNDKMKGFY RSKYTTPSGE VRYAAVTQFE
     ATDARRAFPC WDEPAIKATF DISLVVPKDR VALSNMNVID RKPYPDDENL VEVKFARTPV
     MSTYLVAFVV GEYDFVETRS KDGVCVRVYT PVGKAEQGKF ALEVAAKTLP FYKDYFNVPY
     PLPKIDLIAI ADFAAGAMEN WGLVTYRETA LLIDPKNSCS SSRQWVALVV GHELAHQWFG
     NLVTMEWWTH LWLNEGFASW IEYLCVDHCF PEYDIWTQFV SADYTRAQEL DALDNSHPIE
     VSVGHPSEVD EIFDAISYSK GASVIRMLHD YIGDKDFKKG MNMYLTKFQQ KNAATEDLWE
     SLENASGKPI AAVMNTWTKQ MGFPLIYVEA EQVEDDRLLR LSQKKFCAGG SYVGEDCPQW
     MVPITISTSE DPNQAKLKIL MDKPEMNVVL KNVKPDQWVK LNLGTVGFYR TQYSSAMLES
     LLPGIRDLSL PPVDRLGLQN DLFSLARAGI ISTVEVLKVM EAFVNEPNYT VWSDLSCNLG
     ILSTLLSHTD FYEEIQEFVK DVFSPIGERL GWDPKPGEGH LDALLRGLVL GKLGKAGHKA
     TLEEARRRFK DHVEGKQILS ADLRSPVYLT VLKHGDGTTL DIMLKLHKQA DMQEEKNRIE
     RVLGATLLPD LIQKVLTFAL SEEVRPQDTV SVIGGVAGGS KHGRKAAWKF IKDNWEELYN
     RYQGGFLISR LIKLSVEGFA VDKMAGEVKA FFESHPAPSA ERTIQQCCEN ILLNAAWLKR
     DAESIHQYLL QRKASPPTV
//
